Product Information
NORETHIND-ETH ESTRAD 1-0.02 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1741 per EA under NDC 00378728053. Its NADAC has been published 616 times since Sep 10, 2014.
Strength
.02; 1 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378728053
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA202771On Market Since
7/11/2014
Price Statistics
The NADAC for NORETHIND-ETH ESTRAD 1-0.02 MG has been published 616 times since Sep 10, 2014, and over the history we have for it it has declined 75.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1741 per EA |
|---|---|
| All-time high | $0.8827 (Jan 13, 2016) |
| All-time low | $0.1619 (Nov 20, 2024) |
| 52-week high | $0.1797 |
| 52-week low | $0.1652 |
| Median price | $0.3532 |
| Average price | $0.4162 |
| Largest weekly change | +37.1% (May 22, 2019) |
| Weeks tracked | 616 |
| Tracking since | Sep 10, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NORETHIND-ETH ESTRAD 1-0.02 MG?
The current National Average Drug Acquisition Cost (NADAC) for NORETHIND-ETH ESTRAD 1-0.02 MG, manufactured by Mylan Pharmaceuticals Inc., is $0.1741 per EA (NDC 00378728053), effective Jun 24, 2026.
How has the price of NORETHIND-ETH ESTRAD 1-0.02 MG changed over time?
Over the history we have for it, the NADAC for NORETHIND-ETH ESTRAD 1-0.02 MG has declined 75.0%. It has been tracked across 616 weekly CMS publications since Sep 10, 2014.
What are the highest and lowest recorded NADAC prices for NORETHIND-ETH ESTRAD 1-0.02 MG?
Since Sep 10, 2014, the NADAC for NORETHIND-ETH ESTRAD 1-0.02 MG has ranged from a low of $0.1619 (Nov 20, 2024) to a high of $0.8827 (Jan 13, 2016), with a median of $0.3532 per EA.
Are there cheaper alternatives to NORETHIND-ETH ESTRAD 1-0.02 MG?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as NORETHIND-ETH ESTRAD 1-0.02 MG, but none are currently priced below it.
Who manufactures NORETHIND-ETH ESTRAD 1-0.02 MG?
NORETHIND-ETH ESTRAD 1-0.02 MG (NDC 00378728053) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification